Literature DB >> 33445653

Seeding Propensity and Characteristics of Pathogenic αSyn Assemblies in Formalin-Fixed Human Tissue from the Enteric Nervous System, Olfactory Bulb, and Brainstem in Cases Staged for Parkinson's Disease.

Alexis Fenyi1, Charles Duyckaerts2, Luc Bousset1, Heiko Braak3, Kelly Del Tredici3, Ronald Melki1.   

Abstract

We investigated α-synuclein's (αSyn) seeding activity in tissue from the brain and enteric nervous system. Specifically, we assessed the seeding propensity of pathogenic αSyn in formalin-fixed tissue from the gastric cardia and five brain regions of 29 individuals (12 Parkinson's disease, 8 incidental Lewy body disease, 9 controls) using a protein misfolding cyclic amplification assay. The structural characteristics of the resultant αSyn assemblies were determined by limited proteolysis and transmission electron microscopy. We show that fixed tissue from Parkinson's disease (PD) and incidental Lewy body disease (ILBD) seeds the aggregation of monomeric αSyn into fibrillar assemblies. Significant variations in the characteristics of fibrillar assemblies derived from different regions even within the same individual were observed. This finding suggests that fixation stabilizes seeds with an otherwise limited seeding propensity, that yield assemblies with different intrinsic structures (i.e., strains). The lag phase preceding fibril assembly for patients ≥80 was significantly shorter than in other age groups, suggesting the existence of increased numbers of seeds or a higher seeding potential of pathogenic αSyn with time. Seeding activity did not diminish in late-stage disease. No statistically significant difference in the seeding efficiency of specific regions was found, nor was there a relationship between seeding efficiency and the load of pathogenic αSyn in a particular region at a given neuropathological stage.

Entities:  

Keywords:  Lewy body disease; Parkinson’s disease; alpha-synuclein; enteric nervous system; incidental Lewy body disease; prion-like; protein misfolding cyclic amplification (PMCA); synuclein strains; synucleinopathy

Year:  2021        PMID: 33445653      PMCID: PMC7828121          DOI: 10.3390/cells10010139

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  55 in total

Review 1.  Inactivation of prions by physical and chemical means.

Authors:  D M Taylor
Journal:  J Hosp Infect       Date:  1999-12       Impact factor: 3.926

2.  PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.

Authors:  Medeva Ghee; Ronald Melki; Nadine Michot; Jacques Mallet
Journal:  FEBS J       Date:  2005-08       Impact factor: 5.542

3.  Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.

Authors:  Jeffrey H Kordower; Yaping Chu; Robert A Hauser; Thomas B Freeman; C Warren Olanow
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

4.  Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology.

Authors:  Karin M Danzer; Simon K Krebs; Michael Wolff; Gerald Birk; Bastian Hengerer
Journal:  J Neurochem       Date:  2009-08-04       Impact factor: 5.372

5.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Authors:  Jia-Yi Li; Elisabet Englund; Janice L Holton; Denis Soulet; Peter Hagell; Andrew J Lees; Tammaryn Lashley; Niall P Quinn; Stig Rehncrona; Anders Björklund; Håkan Widner; Tamas Revesz; Olle Lindvall; Patrik Brundin
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

Review 6.  Mammalian prions and their wider relevance in neurodegenerative diseases.

Authors:  John Collinge
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

7.  Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice.

Authors:  Kelvin C Luk; Victoria M Kehm; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M Y Lee
Journal:  J Exp Med       Date:  2012-04-16       Impact factor: 14.307

8.  Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo.

Authors:  Elodie Angot; Jennifer A Steiner; Carla M Lema Tomé; Peter Ekström; Bengt Mattsson; Anders Björklund; Patrik Brundin
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

9.  Propagation of pathological α-synuclein in marmoset brain.

Authors:  Aki Shimozawa; Maiko Ono; Daisuke Takahara; Airi Tarutani; Sei Imura; Masami Masuda-Suzukake; Makoto Higuchi; Kazuhiko Yanai; Shin-Ichi Hisanaga; Masato Hasegawa
Journal:  Acta Neuropathol Commun       Date:  2017-02-02       Impact factor: 7.801

10.  Structural and functional characterization of two alpha-synuclein strains.

Authors:  Luc Bousset; Laura Pieri; Gemma Ruiz-Arlandis; Julia Gath; Poul Henning Jensen; Birgit Habenstein; Karine Madiona; Vincent Olieric; Anja Böckmann; Beat H Meier; Ronald Melki
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  4 in total

1.  Disease Mechanisms of Multiple System Atrophy: What a Parallel Between the Form of Pasta and the Alpha-Synuclein Assemblies Involved in MSA and PD Tells Us.

Authors:  Ronald Melki
Journal:  Cerebellum       Date:  2022-06-03       Impact factor: 3.847

2.  Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies.

Authors:  Mie Kristine Just; Hjalte Gram; Vasileios Theologidis; Poul Henning Jensen; K Peter R Nilsson; Mikael Lindgren; Karoline Knudsen; Per Borghammer; Nathalie Van Den Berge
Journal:  Front Aging Neurosci       Date:  2022-05-26       Impact factor: 5.702

Review 3.  The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline.

Authors:  Per Borghammer
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 4.  Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management.

Authors:  K Del Tredici; W H Jost; T Warnecke; K-H Schäfer; I Claus
Journal:  NPJ Parkinsons Dis       Date:  2022-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.